Lingjun Rao
Overview
Explore the profile of Lingjun Rao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li H, Shadrin I, Helfer A, Heman K, Rao L, Curtis C, et al.
Acta Biomater
. 2024 Nov;
PMID: 39528062
Engineered human cardiac tissues hold great promise for disease modeling, drug development, and regenerative therapy. For regenerative applications, successful engineered tissue engraftment in vivo requires rapid vascularization and blood perfusion...
2.
Zhan R, Rao L, Chen Z, Strash N, Bursac N
Acta Biomater
. 2021 Mar;
126:144-153.
PMID: 33705988
The level of circulating interferon-γ (IFNγ) is elevated in various clinical conditions including autoimmune and inflammatory diseases, sepsis, acute coronary syndrome, and viral infections. As these conditions are associated with...
3.
Chen Z, Li B, Zhan R, Rao L, Bursac N
Sci Adv
. 2021 Feb;
7(4).
PMID: 33523949
Chronic inflammatory diseases often lead to muscle wasting and contractile deficit. While exercise can have anti-inflammatory effects, the underlying mechanisms remain unclear. Here, we used an in vitro tissue-engineered model...
4.
Wang J, Khodabukus A, Rao L, Vandusen K, Abutaleb N, Bursac N
Biomaterials
. 2019 Aug;
221:119416.
PMID: 31419653
Skeletal muscle is the largest organ of human body with several important roles in everyday movement and metabolic homeostasis. The limited ability of small animal models of muscle disease to...
5.
Rao L, Qian Y, Khodabukus A, Ribar T, Bursac N
Nat Commun
. 2018 Jan;
9(1):126.
PMID: 29317646
The generation of functional skeletal muscle tissues from human pluripotent stem cells (hPSCs) has not been reported. Here, we derive induced myogenic progenitor cells (iMPCs) via transient overexpression of Pax7...
6.
Gong L, Pan X, Chen H, Rao L, Zeng Y, Hang H, et al.
Sci Rep
. 2016 Nov;
6:37281.
PMID: 27874035
Human induced pluripotent stem (iPS) cells have great potential in regenerative medicine, but this depends on the integrity of their genomes. iPS cells have been found to contain a large...
7.
Cui D, Wang J, Zeng Y, Rao L, Chen H, Li W, et al.
Biosci Biotechnol Biochem
. 2016 Apr;
80(8):1484-91.
PMID: 27068360
Human embryonic stem cells (hESCs) are thought to be a promising resource for cell therapy, while it has to face the major problem of graft immunological rejection. Major histocompatibility complex...
8.
Lu P, Chen J, He L, Ren J, Chen H, Rao L, et al.
Stem Cell Rev Rep
. 2013 Aug;
9(6):806-13.
PMID: 23934228
Immune rejection hinders the application of human embryonic stem cells (hESCs) in transplantation therapy. Human leukocyte antigens (HLAs) on the cell surface are the major cause of graft rejection. In...
9.
Rao L, Tang W, Wei Y, Bao L, Chen J, Chen H, et al.
Stem Cell Rev Rep
. 2012 Oct;
8(4):1109-19.
PMID: 23104134
Human embryonic stem cells (hESCs) are a promising model for the research of embryonic development and regenerative medicine. Since the first hESC line was established, many researchers have shown that...
10.
Ren J, Pak Y, He L, Qian L, Gu Y, Li H, et al.
Cell Res
. 2011 Mar;
21(5):849-53.
PMID: 21403680
No abstract available.